RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
about
The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotectionErythropoiesis-stimulating agents in the management of cancer patients with anemia: a meta-analysis.The effect of erythropoietin on normal and neoplastic cells.The erythropoietin/erythropoietin receptor signaling pathway promotes growth and invasion abilities in human renal carcinoma cells.Erythropoietin and cancer: the unintended consequences of anemia correctionPromises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome.Far-western blotting as a solution to the non-specificity of the anti-erythropoietin receptor antibodyPotential use of RNA interference in cancer therapy.Growth factors controlling ovarian functions.VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesisErythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.Erythropoietin receptor contributes to melanoma cell survival in vivo.Erythropoietin increases macrophage-mediated T cell suppression.Lack of expression and function of erythropoietin receptors in the kidney.
P2860
Q28565261-78F2BE03-84E8-4EE7-8AF6-13251E382ED4Q33827405-9D254904-E7D4-4AA5-B68E-67841C11DF25Q34291437-5299D531-DC2B-4B05-99BF-F2663304183AQ34428148-A9CAC0E7-C985-43A4-A400-6B79EBF7FEB0Q34488415-3B1A9439-FB5E-4CAB-96DB-87FA4D4AF10BQ34504572-2DB71A21-CDF7-4CD5-A304-091EFF5286F7Q35906593-ED55C040-02DB-4466-B973-15051833C1DEQ37107771-AA9A63DA-4C14-4BF5-9B29-94A5215AB5CEQ37780603-E7C8D684-AB13-465C-84B3-E6DF31DB8025Q37887631-233FE92F-620C-44E0-A813-BC06A7BB0751Q38560836-876364E3-0DA9-4E02-90AA-420063CCAEA5Q39250670-4F370060-A4C5-4191-B69B-77B36B45ACEEQ39372905-66132620-31A3-4374-AA67-007DD6D2B336Q39486076-F00F5025-9233-48E4-A08A-449664267D4FQ41807007-2780DFAD-4DAB-4871-A0F7-34F611CE8F90Q45212121-AE25668B-582F-401D-9E6E-8E07B780454E
P2860
RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
RNA interference-mediated inhi ...... human ovarian carcinoma cells.
@en
RNA interference-mediated inhi ...... human ovarian carcinoma cells.
@nl
type
label
RNA interference-mediated inhi ...... human ovarian carcinoma cells.
@en
RNA interference-mediated inhi ...... human ovarian carcinoma cells.
@nl
prefLabel
RNA interference-mediated inhi ...... human ovarian carcinoma cells.
@en
RNA interference-mediated inhi ...... human ovarian carcinoma cells.
@nl
P2093
P2860
P1476
RNA interference-mediated inhi ...... human ovarian carcinoma cells.
@en
P2093
Gyorgy Paragh
Soek-Choel Choi
Suresh M Kumar
Xiaowei Xu
Zsuzsa Rakosy
P2860
P304
P356
10.2353/AJPATH.2009.080592
P407
P577
2009-03-05T00:00:00Z